Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04060342
Title GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR


No variant requirements are available.